Declined. After the end of trading on the 11th, the performance for the first quarter of the May 2025 period was announced. Revenue increased steadily by 44.1% compared to the same period last year, reaching ¥0.441 billion, while operating profit increased by 18.1% to ¥0.086 billion. The increase in the number of accounts of F&I service's debt buying companies and the sale of large medical-related equipment by C&Br services contributed to this positive performance. In addition, in HR&OS services, preparations are progressing towards expanding outsourcing services, with an expected increase in revenue from the second quarter onward. However, the positive impact on the stock price is limited.